Consistent with the findings in the mouse model, in human hepatocellular carcinoma, p62- and KEAP1-positive aggregates are abundant, suggesting that successive NRF2 activation contributes to the development of hepatocellular carcinoma [45]. Here, NFE2L2 is linked to hepatocellular carcinoma.